TRF-BUDESONIDE AND SPARSENTAN AS AN INITIAL THERAPY FOR PRIMARY IgA NEPHRITIS

  Back

E-Poster

https://storage.unitedwebnetwork.com/files/1099/134b2d231c1a5a29714d61551af77af7.pdf

Abstract Title

TRF-BUDESONIDE AND SPARSENTAN AS AN INITIAL THERAPY FOR PRIMARY IgA NEPHRITIS

First Name *

Neeharik

Last Name *

Mareedu

Co-author 1

Praveen Errabelli erabelli.praveen@mayo.edu Mayo Clinic Health System Nephrology Eau Claire

Co-author 2

 

Co-author 3

 

Co-author 4

 

Co-author 5

 

Co-author 6

 

Co-author 7

 

Co-author 8

 

Co-author 9

 

Co-author 10

 

Co-author 11

 

Co-author 12

 

Co-author 13

 

Co-author 14

 

Co-author 15

 

E-Poster Format Requirements

• PDF file
• Layout: Portrait (vertical orientation)
• One page only (Dim A4: 210 x 297mm or PPT)
• E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
• File Size: Maximum file size is 2 Megabytes (2 MB)
• No hyperlinks, animated images, animations, and slide transitions
• Language: English
• Include your abstract number
• E-posters can include QR codes, tables and photos